Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Lei Deng, Lesli A. Kiedrowski, Elizabeth Ravera, Haiying Cheng, Balazs Halmos

Research output: Contribution to journalLetterpeer-review

38 Scopus citations
Original languageEnglish (US)
Pages (from-to)e169-e172
JournalJournal of Thoracic Oncology
Issue number9
StatePublished - Sep 2018

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this